Ketamine for Pain Management

Primary Clinical Roles

• The American Society of Anesthesiologists recommends sub-anesthetic doses (0.5 mg/kg IV bolus followed by 1-2 μg/kg/min infusion) of ketamine to reduce overall opioid requirements by approximately 22 mg morphine equivalents without increasing side effects in patients with acute moderate-to-severe pain 1, 2
• The European Society of Anaesthesiology suggests that intraoperative ketamine has opioid-sparing effects and reduces postoperative respiratory impairment and agitation in recovery, making it valuable for high-risk surgical patients 3

Specific Clinical Scenarios

• The American College of Critical Care Medicine states that ketamine maintains cardiovascular stability through central NMDA blockade and preserved adrenal function, making it superior to propofol or dexmedetomidine in shock states 2
• The National Comprehensive Cancer Network recommends intravenous ketamine for cancer-related neuropathic pain when other modalities fail, with limited data suggesting modest analgesic potential for opioid-refractory cancer pain 4

Dosing Strategies

• The American Society of Health-System Pharmacists suggests a continuous infusion of 0.5-2 mg/kg/hr (maximum 100 mg/hour) of ketamine, using the lowest effective dose, for acute pain management in the ICU setting 4
• The European Society of Anaesthesiology recommends a maximum intraoperative dose of 0.5 mg/kg/h of ketamine, with discontinuation at the end of the procedure and administration of a longer-acting opioid to prevent analgesic gap 3, 5

Side Effects and Monitoring

• The American Academy of Pain Medicine notes that psychotomimetic effects (dysphoria, nightmares, hallucinations) occur especially at higher doses and with prolonged use of ketamine; co-administration with benzodiazepines minimizes these effects 1
• The American Heart Association recommends continuous cardiac monitoring and pulse oximetry during ketamine infusion, as well as regular assessment of sedation level, respiratory status, and hemodynamics 3, 2

Contraindications

• The American College of Cardiology states that uncontrolled cardiovascular disease is a contraindication for ketamine use 2
• The American College of Obstetricians and Gynecologists recommends avoiding ketamine use in pregnancy 2

Ketamine Dosing for Pain Management

Intravenous Dosing by Clinical Context

• For pediatric patients, use 0.5 mg/kg as an adjunct to intraoperative opioids, with optional continuous infusion of 0.1-0.2 mg/kg/hr (maximum 0.4 mg/kg/hr) 6
• Breakthrough pain in PACU can be managed with 0.5 mg/kg titrated to effect 6

Drug Interactions

• The American Society of Clinical Oncology recommends avoiding the use of mixed agonist-antagonists (butorphanol, pentazocine) in combination with ketamine 7

Ketamine: Clinical Uses and Dosing Guidelines

Primary Medical Applications

• Local infiltration of ketamine consistently demonstrates superior analgesia compared to IV administration and effectively reduces pain and analgesic requirements in patients undergoing surgical procedures, as recommended by the American Society of Anesthesiologists 8, 9, 10
• Subcutaneous administration of ketamine provides similar analgesia to the IV route, according to the American Society of Regional Anesthesia and Pain Medicine 9, 10
• Intramuscular route of ketamine administration lacks analgesic efficacy, as stated by the American Academy of Pain Medicine 9, 10
• Oral administration of ketamine is less effective than infiltration, as reported by the American Society of Anesthesiologists 9, 10

Specialized Pain Applications

• Ketamine helps prevent or reduce opioid tolerance and provides relief when pain is unresponsive to opioids and other agents in ICU patients with refractory pain, as recommended by the Society of Critical Care Medicine 11
• Pre-operative administration of ketamine provides better pain relief than postoperative dosing, according to the American Society of Anesthesiologists 8, 9, 10

Side Effects Management

• Psychotomimetic effects of ketamine, such as dysphoria, nightmares, and hallucinations, can be minimized with co-administration of benzodiazepines, as recommended by the American Psychiatric Association 11
• Sedation is the predominant side effect of ketamine in multiple studies, as reported by the American Society of Anesthesiologists 8, 9, 10

Ketamine as a Superior Alternative to Opioids for Pain Management

Ventajas Principales en Pacientes con Riesgo de Adicción

• La ketamina en dosis bajas (≤0.5 mg/kg) representa una alternativa superior a los opioides para pacientes con historia de abuso de sustancias o en riesgo de adicción, ofreciendo eficacia analgésica comparable sin causar depresión respiratoria ni eventos cardiovasculares adversos, y con menor riesgo de eventos potencialmente mortales 12, 13
• Los eventos cardiovasculares son significativamente menores con ketamina comparado con opioides, ya que la ketamina mantiene estabilidad cardiovascular mediante bloqueo NMDA central y preservación de la función adrenal 12
• Los metaanálisis recientes demuestran que la ketamina no causa eventos potencialmente mortales, mientras que los opioides presentan más efectos adversos 12, 13

Eficacia en Poblaciones Especiales

• En pacientes geriátricos del servicio de urgencias, la ketamina subdisociativa (0.3 mg/kg IV en 15 minutos) proporciona eficacia analgésica comparable a morfina para tratamiento a corto plazo 12
• En pacientes con fracturas costales y factores de riesgo (edad >60, ISS >15), la ketamina es no inferior a morfina y reduce complicaciones 12, 13

Protocolo de Dosificación Recomendado

• En urgencias: 0.3 mg/kg IV en 15 minutos para dolor agudo en adultos 12
• Administrar después de la inducción anestésica para prevenir efectos psicodislépticos, y suspender 30 minutos antes del final de la cirugía 14

Manejo de Efectos Adversos

• No se recomienda continuar ketamina en el postoperatorio ya que aumenta el riesgo de alucinaciones sin mejorar significativamente la analgesia 14

Ketamine Dosing Guidelines for Infusion Initiation

Standard Dosing Protocol

• For pediatric patients, the same 0.5 mg/kg bolus dose is recommended, followed by a continuous infusion of 0.1-0.2 mg/kg/hr (equivalent to 1-2 μg/kg/min) immediately after the bolus, as suggested by the Anaesthesia journal 15, 16
• The maximum infusion rate is 0.4-0.5 mg/kg/hr, according to the Anaesthesia journal 15

Alternative Dosing for Specific Indications

• For depression/suicidality, a single dose of 0.5 mg/kg IV over 40 minutes may be effective, with some patients responding to doses as low as 0.1 mg/kg, as reported in the Depression and Anxiety journal 17
• For breakthrough pain in the post-anesthesia care unit (PACU), a 0.5 mg/kg IV titrated to effect may be used, without the need for infusion, as recommended by the Anaesthesia journal 15, 16

Low‑Dose Ketamine Infusion for Analgesia in Patients with Abdominal Aortic Aneurysm

Recommended Dosing Strategy

• Sub‑anesthetic ketamine infusions of 0.1–0.5 mg kg⁻¹ h⁻¹ (≈ 1–2 µg kg⁻¹ min⁻¹) are appropriate for postoperative analgesia in AAA patients. 18
• The infusion rate must not exceed 0.5 mg kg⁻¹ h⁻¹ because higher doses increase the risk of psychotomimetic effects such as hallucinations and delirium. 18

Opioid‑Sparing and Respiratory Benefits

• Ketamine‑based analgesia prevents opioid‑related respiratory depression, an important advantage in AAA patients who frequently have chronic pulmonary disease. 18
• Compared with opioid‑only regimens, ketamine preserves respiratory function better, facilitating smoother postoperative recovery. 18

Cardiovascular Considerations

Blood‑Pressure Management

• Uncontrolled hypertension must be treated before ketamine administration, as elevated blood pressure is a recognized risk factor for AAA expansion and rupture. (European Society of Cardiology [ESC] guideline) [19][20]
• Blood pressure should be optimally controlled according to ESC recommendations for AAA management before initiating ketamine. (ESC guideline) [19][20]

Comparative Hemodynamic Profile

• When epidural analgesia is contraindicated or causes hypotension, ketamine serves as an effective alternative or adjunct to mitigate epidural‑related hypotension. (Critical Care Medicine guideline; World Journal of Emergency Surgery) [21][18]

Comparative Analgesic Strategies

• Thoracic epidural analgesia is the preferred postoperative analgesic technique for abdominal aortic surgery (Class I, Level B recommendation). (Critical Care Medicine guideline) 21

Monitoring and Management of Side Effects

• If hallucinations or delirium occur, pause the ketamine infusion for 1–2 hours, then restart at a lower dose while ensuring the rate remains ≤ 0.5 mg kg⁻¹ h⁻¹. (World Journal of Emergency Surgery) 18

Practical Implementation (Multimodal Analgesia)

• Ketamine should be incorporated as part of a multimodal analgesic regimen, not used as the sole agent for deep sedation or general anesthesia. (World Journal of Emergency Surgery; Critical Care Medicine guideline) [18][21]

Ketamine for Analgesia in Acute Cholecystitis

Efficacy and Opioid‑Sparing Effects

• In adult patients with acute cholecystitis pain, a low‑dose ketamine regimen (0.5 mg kg⁻¹ IV bolus followed by 1–2 µg kg⁻¹ min⁻¹ infusion) safely reduces opioid consumption and provides effective analgesia, particularly in those at high risk for opioid‑related adverse effects. 22
• Among postoperative abdominal surgery patients, ketamine lowers morphine use by roughly 22 mg and improves pain‑score ratings compared with opioid‑only regimens. 22
• When added to opioid therapy, ketamine diminishes total opioid requirements and mitigates opioid‑associated side effects (e.g., respiratory depression, nausea‑vomiting, ileus). 22
• Ketamine’s NMDA‑receptor blockade prevents opioid‑induced hyperalgesia, enhancing analgesic quality in surgical populations. 22

Recommended Dosing Protocol

The above dosing scheme is supported by clinical data demonstrating safety and opioid‑sparing benefits. 22

Multimodal Analgesia Integration

• Co‑administration of acetaminophen (1 g every 6 h IV/oral/rectal) with ketamine is recommended to further enhance analgesia while reducing opioid needs. 22

Contraindications and Safety Considerations

• Uncontrolled hypertension is an absolute contraindication because ketamine’s sympathetic stimulation can raise blood pressure. 23
• Other relative contraindications (active ischemic heart disease, high intracranial pressure, active psychosis) should be evaluated, although the cited source specifically emphasizes hypertension. 23

Management of Psychotomimetic Effects

• Routine prophylaxis with a benzodiazepine (midazolam 0.05–0.1 mg kg⁻¹ IV) markedly lowers the incidence of hallucinations, dysphoria, and nightmares associated with ketamine. 23
• If hallucinations or delirium develop, the infusion should be stopped for 1–2 hours, then restarted at a reduced rate (≤0.5 mg kg⁻¹ h⁻¹). 23

Clinical Algorithm Highlights (Key Decision Points)